Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Topical Ocular Hypotensive Medication Compliance
NCT00329095Phase 4Completed
- Start
- Dec 2005
- Modality
- Prodrugs/Conditional Activator Small Molecules, Orthosteric Ligands
01
Overview
A Phase 4 trial of travoprost, latanoprost ophthalmic solution 0.005% (TearClear TC-002), bimatoprost in Glaucoma, ocular hypertension. Started Dec 2005; status: completed.
02
Drugs
travoprostlatanoprost ophthalmic solution 0.005% (TearClear TC-002)bimatoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00329095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00329095.